Monash Ivf Group Ltd
Monash IVF Group Limited engages in the provision of assisted reproductive and specialist women imaging services in Australia and Malaysia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Richmond, Au… Read more
Monash Ivf Group Ltd (MVF) - Total Assets
Latest total assets as of December 2025: AU$510.21 Million AUD
Based on the latest financial reports, Monash Ivf Group Ltd (MVF) holds total assets worth AU$510.21 Million AUD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Monash Ivf Group Ltd - Total Assets Trend (2013–2025)
This chart illustrates how Monash Ivf Group Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Monash Ivf Group Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Monash Ivf Group Ltd's total assets of AU$510.21 Million consist of 8.5% current assets and 91.5% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$543.00K | 1.9% |
| Accounts Receivable | AU$7.91 Million | 1.6% |
| Inventory | AU$9.00 Million | 1.8% |
| Property, Plant & Equipment | AU$146.04 Million | 29.7% |
| Intangible Assets | AU$23.88 Million | 4.9% |
| Goodwill | AU$273.35 Million | 55.5% |
Asset Composition Trend (2013–2025)
This chart illustrates how Monash Ivf Group Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Monash Ivf Group Ltd's current assets represent 8.5% of total assets in 2025, a decrease from 17.4% in 2013.
- Cash Position: Cash and equivalents constituted 1.9% of total assets in 2025, down from 15.3% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 59.0% of total assets, a decrease from 78.0% in 2013.
- Asset Diversification: The largest asset category is goodwill at 55.5% of total assets.
Monash Ivf Group Ltd Competitors by Total Assets
Key competitors of Monash Ivf Group Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Monash Ivf Group Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Monash Ivf Group Ltd generates 0.55x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Monash Ivf Group Ltd generates $5.08 in net profit.
Monash Ivf Group Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.82 | 0.61 | 0.70 |
| Quick Ratio | 0.62 | 0.51 | 0.58 |
| Cash Ratio | 0.00 | 0.08 | 0.23 |
| Working Capital | AU$-9.89 Million | AU$ -35.79 Million | AU$ -10.01 Million |
Monash Ivf Group Ltd - Advanced Valuation Insights
This section examines the relationship between Monash Ivf Group Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.99 |
| Latest Market Cap to Assets Ratio | 0.24 |
| Asset Growth Rate (YoY) | -3.1% |
| Total Assets | AU$492.61 Million |
| Market Capitalization | $116.82 Million USD |
Valuation Analysis
Below Book Valuation: The market values Monash Ivf Group Ltd's assets below their book value (0.24 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Monash Ivf Group Ltd's assets decreased by 3.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Monash Ivf Group Ltd (2013–2025)
The table below shows the annual total assets of Monash Ivf Group Ltd from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$492.61 Million | -3.12% |
| 2024-06-30 | AU$508.47 Million | +20.52% |
| 2023-06-30 | AU$421.89 Million | +8.99% |
| 2022-06-30 | AU$387.10 Million | +8.68% |
| 2021-06-30 | AU$356.17 Million | +0.55% |
| 2020-06-30 | AU$354.22 Million | +22.13% |
| 2019-06-30 | AU$290.04 Million | -0.20% |
| 2018-06-30 | AU$290.61 Million | +1.17% |
| 2017-06-30 | AU$287.25 Million | -0.09% |
| 2016-06-30 | AU$287.52 Million | +1.58% |
| 2015-06-30 | AU$283.05 Million | +14.89% |
| 2014-06-30 | AU$246.36 Million | -7.25% |
| 2013-06-30 | AU$265.61 Million | -- |